SmartSignals Analytics

Outcomes Analytics

Get actionable insights that you can trust 

What are Outcomes Analytics?

SmartSignals Outcomes Analytics is an adaptive risk-based data monitoring program that adds a layer of checks to your study by applying clinician-defined algorithms to electronic clinician ratings, ePRO, and other source data to identify trends, anomalies, or statistically significant discrepancies. With Outcomes Analytics, you will be able to identify and proactively resolve potential issues to ensure high quality data.  

How does outcome analytics work?

SmartSignals Outcomes Analytics examines study data at all relevant levels (rater, site, country, region, and study) to identify clinically relevant quality concerns and presents findings in graphic visualizations, making interpretation and analysis simple.  

Your team will be able to monitor the collected data quality throughout the course of the trial using a variety of views and outputs to extract key insights, such as verifying that sites are adhering to protocol requirements. 

Why choose SmartSignals?

Signant Health combines clinical and data science to help you maximize your study’s potential and monitor performance with greater clarity. We provide not just eCOA technology, but the scientific advisory and business intelligence you need to deliver primary and secondary endpoints with confidence in data quality and accuracy. Explore our full SmartSignals suite of end-to-end solutions to see why sponsors and CROs rely on Signant Health for optimized evidence generation.  

Frequently Asked Questions

Can clinical outcome analytics be performed for any indication?

Outcome Analytics provides centralized statistical review of eCOA data for any therapeutic area or indication. Signant Health will tailor the clinical data analyses based on the data collected.

How is Outcome Analytics different from the standard dashboard reporting of eCOA data?

Outcome Analytics goes beyond standard eCOA reporting by deploying statistical analyses to identify data manipulation, fraud, carelessness, or other indicators of poor clinical data quality.

What is risk based monitoring (RBM) in clinical trials?

Risk-based monitoring is the process of ensuring the quality of clinical trials by identifying, assessing, monitoring and mitigating the risks that could affect the quality or safety of a study.

Want to learn more?

Add data analytics to your study to get visibility and insights – contact our clinical data team today!